Partnerships and Collaborations
We work closely with foundations, biotech firms and pharmaceutical companies to develop new models and further translational research.
GRS Currated List
Resource and Model Development
We develop models for basic research, tools for exploring disease mechanisms on a molecular level and precision models of human disease.
Faculty & Staff
Funding
Genetic Resource Science is funded by NIH research and resource grants, private foundations and revenue from the distribution of mice to researchers.
National Cancer Institute
National Heart, Lung and Blood Institute
National Human Genome Research Institute
National Institute of Child Health and Human
Development
National Institute of Dental and Craniofacial
Research
National Institute of Diabetes and Digestive
and Kidney Diseases
National Institute on Neurological Disorders
and Stroke
Office of Research Infrastructure Programs,
Office of the Director, NIH
ALS Therapy Alliance
Amyotrophic Lateral Sclerosis Association
Chordoma Foundation
Cicatricial Alopecia Research Foundation
Council for Nail Disorders
Dravet Syndrome Foundation
Families of SMA
Friedreich's Ataxia Research Alliance
March of Dimes
Michael J. Fox Foundation
Spinal Muscular Atrophy Foundation
The Tow Foundation
-
Featured ArticleApril 23, 2024Dan Cortes: gearing up for discovery
Dan Cortes multifaceted journey has led him to pioneering stem cell research within the Pera lab, where he explores the intricate genetic landscape underlying neurological diseases and disorders. -
Featured ArticleApril 16, 2024Incorporating diverse background genetics to better model human disease
JAX scientists are working to make it more feasible for researchers to incorporate diverse background genetics to better model human disease in mice. -
Featured ArticleMarch 26, 2024Working to characterize the function of protein-coding genes in the mouse
Using KOMP2, JAX researchers have now generated and characterized more than 2,000 knockout mice, gaining important insights into mammalian genetics and potential health impacts. -
Press ReleaseMarch 11, 2024JAX and LG AI Research partner to pioneer biomedical advancements
Two world-leading organizations are partnering to further expand AI capabilities in biomedical science and catalyze medical progress.
-
Research HighlightApril 16, 2024Developing immune therapy without immune toxicity
A team led by David Serreze presents a mouse model for studying severe immune checkpoint inhibition-based damage to heart and skeletal muscle, providing an important resource for maximizing the benefits and minimizing the side effects of vital immunotherapies. -
Research HighlightApril 03, 2024Making mice a more powerful research tool
A new protocol sets the stage for researchers to directly compare mouse and human cells, and readily incorporates genetic diversity into mouse-based research to more closely approximate human health conditions. -
Research HighlightMarch 26, 2024CRISPR provides potential cardiomyopathy treatment
JAX researchers have developed a potential new treatment for dilated cardiomyopathy (DCM), a sometimes fatal heart condition that affects as many as one in 200 adults worldwide. -
Search MagazineMarch 05, 2024A lifelong career in research
A look into Beth Dumont's work with JAX, tracing her time from summer student to an associate professor on the JAX faculty.